Resources

Everything we learned walking API trains.

Practical material for manufacturing, science, and quality teams evaluating autonomous control of drug-substance production.

Built for the plants that make the world’s small molecules

  • Branded pharma
  • Generics
  • CDMOs
  • Fine chemicals
  • Peptide APIs
  • High-potency APIs
  • Continuous plants

Whitepapers

Deep dives

Long-form technical material. [PLACEHOLDER — publication in progress]

Whitepaper

Autonomous crystallization control: a reference architecture

How perception, planning, control, and record-keeping fit together around a crystallizer, and where each one fails without the others.

Read

Whitepaper

Fusing Raman, FBRM, PVM, and NIR

Why single-modality PAT under-determines the crystallization state, and how disagreement between instruments becomes signal.

Read

Whitepaper

Validating AI in a GMP plant

Version locks, change control, audit trails, and the questions your quality unit will ask on the first call.

Read

Templates

Take these into your next meeting

Editable artifacts for scoping and approving a pilot.

Template

Pilot scoping worksheet

Train selection, metric definition, baseline period, and decision criteria on one page.

Read

Template

PAT readiness checklist

What instruments, tags, and access a train needs before a shadow campaign can start.

Read

Template

QA question bank

The questions to ask any AI vendor about audit trails, autonomy, and model version control.

Read

Buyer’s guide

How to evaluate autonomous control honestly

Most industrial AI in pharma is analytics with a chat box. The separating questions are simple: does it perceive the crystal, does it act, and can quality approve what it did?

  • Does it fuse in-line PAT or only read historian tags?
  • Does it write setpoints, or only produce advice?
  • Is every output cited to spectra, images, or documents?
  • Is the audit trail Part 11-ready, or an application log?

Landscape

Where Polymorra sits

A simplified view of the categories teams compare us against.

CategoryPerceives the crystalActs on the plantGMP record
DCS / automation platformsNoYes (fixed logic)Partial
PAT software suitesYes (single modality)NoPartial
Industrial AI analyticsNoNoNo
MES / eBR systemsNoNoYes
PolymorraYes (fused)Yes (bounded)Yes (Part 11)

The autonomous loop

Perceive, plan, act, sense, optimize, log

Polymorra closes the loop around the reaction mass and the crystal — the two things a conventional DCS cannot actually see.

  1. Perceive

    Fuse Raman, FBRM, PVM in-situ imaging, NIR, and reactor telemetry into a live picture of the reaction mass, slurry, and solids.

  2. Plan

    Plan the react-and-charge, crystallize-and-seed, and isolate-and-dry moves for this batch against the target polymorph, particle size, and purity.

  3. Act

    Run with adaptive control: cooling and antisolvent profile, seeding, supersaturation, agitation, addition rate, and endpoint.

  4. Sense & predict

    Predict polymorph, particle size and habit, impurity profile, and yield in-line — before offline XRPD and HPLC confirm it.

  5. Optimize

    Optimize yield, solvent use, cycle time, and reprocessing risk across the campaign, then flag off-spec and polymorph risk early.

  6. Log & retrain

    Write an immutable Part 11 record; every chemist correction trains the site model and compounds the data moat.

Plant-edge console

One screen for the batch that is running right now

Supersaturation, particle size distribution, predicted polymorph, impurity trajectory, and the next control move — with the evidence behind each number.

Polymorra plant-edge console showing live supersaturation, particle size distribution, predicted polymorphic form, and impurity trajectory for a running crystallization, with the recommended next control move.

Integrations

Connects to the systems already running your plant

Polymorra reads and writes through the reactor DCS, PAT instruments, crystallizer and isolation skids, historians, and MES you already validated.

Reactor control & DCS

Emerson DeltaVSiemens PCS 7Honeywell ExperionOPC UAModbus/TCP

PAT & analytics

Mettler-Toledo FBRMPVM in-situ imagingReactIREndress+Hauser RamanNIRHPLC / XRPD imports

Isolation & drying

Nutsche filter-dryersCentrifugesAgitated dryersConical millsMicronizers

MES, historian & quality

Körber PAS-XEmerson SyncadeOSIsoft PILIMSeBR / QMS exports

Trust & compliance

Validated for GMP manufacturing

Polymorra is engineered for regulated drug-substance production: grounded outputs, immutable audit trails, graduated autonomy, and validation documentation from day one.

21 CFR Part 11

Immutable, validated audit log for every agent perception, recommendation, and control action, with e-signature-ready review flows.

GMP / ICH Q7

Change control, validated model versioning, and deployment documentation designed for drug-substance manufacturing.

SOC 2

SOC 2 Type I in progress, Type II on the roadmap; SSO/RBAC, encryption in transit and at rest. [ASPIRATIONAL]

Route & IP protection

Per-tenant isolation of routes, recipes, spectra, and crystal images. No cross-tenant training. On-prem option.

Graduated autonomy

Shadow → assist → bounded auto-control. Every autonomy level is explicitly configured, bounded, and revocable.

Grounded outputs

Every recommendation cites the spectra, images, telemetry, SOP, or specification it was derived from.

Plant-edge first

Inference runs on-site so control loops survive network loss; cloud is for training, fleet, and analytics.

Human-in-the-loop

Chemist and QA checkpoints are first-class: approve, correct, or reject — and every correction trains the models.

Voices from the plant

What operators say

Composite quotes from design-partner discovery interviews. [PLACEHOLDER — to be replaced with named references post-pilot]

“The crystallization step is where our campaigns live or die. Seeing supersaturation, particle size, and predicted polymorph in one place — and having the profile adjust itself — is what we have wanted for twenty years.”
Crystallization & PAT EngineerTop-20 branded pharma · API site
“We do not want another dashboard. We want the batch to come out right and the record to be reviewable by exception. That is the only pitch that gets past QA.”
QA / Regulatory ManagerGeneric API manufacturer
“Tech transfer is our bottleneck. If the twin can predict the plant crystal from the lab crystal, that is worth more than the software costs.”
API Manufacturing DirectorGlobal CDMO

Bring the checklist. We will answer all of it.

Start with one crystallizer or reactor train. Prove polymorph, yield, and reprocessing ROI in a validation-friendly pilot. Then expand across the plant.